Hepatotoxicity SIG: Drug Induced Liver Injury: Assessing Risk and Predicting Outcome
Recorded On: 11/08/2019
Already registered?
Sign in now.
Clinicians and translational researchers will glean approaches to assess drug induced liver injury (DILI) risk and predict outcomes at this session. Faculty will review basic hepatic drug metabolism in healthy and diseased livers, strategies to detect DILI during drug treatment and possible DILI risk factors, such as dose, duration, genetics and immunity. They will also share useful databases for clinicians.
Jay H. Hoofnagle
Craig Lammert
Key:
Complete
Next
Failed
Available
Locked
Dose, Duration and Drug Characteristics as Risk Factors for Liver Injury
Open to view video.
Open to view video.
Presenter: Craig Lammert
Resources to Help the Clinician Manage Hepatotoxicity: Focus on LIVERTOX
Open to view video.
Open to view video.
Presenter: Jay H. Hoofnagle